All Clinical Trials

Clinical Trial

AALL1231, A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)

  • Recruiting participants (Starts Nov. 3, 2014)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: Tamra Lynn Slone

summary

See protocol/CiRB application

eligibility

See protocol

If you are interested in this clinical trial, please contact Princess Iroh on the Children’s Health Research Team.Call 214-590-0608Email